474 related articles for article (PubMed ID: 23974350)
1. Recent insights into Candida albicans biofilm resistance mechanisms.
Mathé L; Van Dijck P
Curr Genet; 2013 Nov; 59(4):251-64. PubMed ID: 23974350
[TBL] [Abstract][Full Text] [Related]
2. Biofilm of Candida albicans: formation, regulation and resistance.
Pereira R; Dos Santos Fontenelle RO; de Brito EHS; de Morais SM
J Appl Microbiol; 2021 Jul; 131(1):11-22. PubMed ID: 33249681
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals.
Watamoto T; Samaranayake LP; Egusa H; Yatani H; Seneviratne CJ
J Med Microbiol; 2011 Sep; 60(Pt 9):1241-1247. PubMed ID: 21474609
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of Candida albicans biofilm.
Tsui C; Kong EF; Jabra-Rizk MA
Pathog Dis; 2016 Jun; 74(4):ftw018. PubMed ID: 26960943
[TBL] [Abstract][Full Text] [Related]
5. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans.
Nobile CJ; Fox EP; Hartooni N; Mitchell KF; Hnisz D; Andes DR; Kuchler K; Johnson AD
mBio; 2014 Jun; 5(3):e01201-14. PubMed ID: 24917598
[TBL] [Abstract][Full Text] [Related]
6. Development and regulation of single- and multi-species Candida albicans biofilms.
Lohse MB; Gulati M; Johnson AD; Nobile CJ
Nat Rev Microbiol; 2018 Jan; 16(1):19-31. PubMed ID: 29062072
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility of Candida albicans in biofilms.
Tobudic S; Kratzer C; Lassnigg A; Presterl E
Mycoses; 2012 May; 55(3):199-204. PubMed ID: 21793943
[TBL] [Abstract][Full Text] [Related]
8. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
De Brucker K; De Cremer K; Cammue BP; Thevissen K
Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
[TBL] [Abstract][Full Text] [Related]
9. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
10. Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species.
Singh R; Kumari A; Kaur K; Sethi P; Chakrabarti A
J Med Microbiol; 2018 Jul; 67(7):922-926. PubMed ID: 29767615
[TBL] [Abstract][Full Text] [Related]
11. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.
Chandra J; Kuhn DM; Mukherjee PK; Hoyer LL; McCormick T; Ghannoum MA
J Bacteriol; 2001 Sep; 183(18):5385-94. PubMed ID: 11514524
[TBL] [Abstract][Full Text] [Related]
12. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
Vediyappan G; Rossignol T; d'Enfert C
Antimicrob Agents Chemother; 2010 May; 54(5):2096-111. PubMed ID: 20194705
[TBL] [Abstract][Full Text] [Related]
13. Candida albicans biofilms: antifungal resistance, immune evasion, and emerging therapeutic strategies.
Fan F; Liu Y; Liu Y; Lv R; Sun W; Ding W; Cai Y; Li W; Liu X; Qu W
Int J Antimicrob Agents; 2022; 60(5-6):106673. PubMed ID: 36103915
[TBL] [Abstract][Full Text] [Related]
14. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation.
Nett JE; Sanchez H; Cain MT; Ross KM; Andes DR
Eukaryot Cell; 2011 Dec; 10(12):1660-9. PubMed ID: 21666076
[TBL] [Abstract][Full Text] [Related]
15. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
Ramage G; López-Ribot JL
Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
[TBL] [Abstract][Full Text] [Related]
16. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
Seneviratne CJ; Jin LJ; Samaranayake YH; Samaranayake LP
Antimicrob Agents Chemother; 2008 Sep; 52(9):3259-66. PubMed ID: 18625775
[TBL] [Abstract][Full Text] [Related]
17. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Gao M; Wang H; Zhu L
Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
[TBL] [Abstract][Full Text] [Related]
18. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
19. A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms.
Pierce CG; Uppuluri P; Tummala S; Lopez-Ribot JL
J Vis Exp; 2010 Oct; (44):. PubMed ID: 21048668
[TBL] [Abstract][Full Text] [Related]
20. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
